Delivery Order SPE2DB20D3303-SPE2DB25FA0WN
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,576.33 for Ondansetron ODT 4 mg tablets (30-count packages) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in military and federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,639.08 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery order has a completion date of September 2, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. Ondansetron is an anti-nausea medication commonly used in military and federal healthcare settings to...
- The Defense Logistics Agency awarded a delivery order valued at $4,279.41 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages). This firm fixed-price, non-set-aside contract was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ondansetron is a pharmaceutical used primarily for nausea and vomiting management in medical settings. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,401.79 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is scheduled for completion by May 1, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in...
- The Defense Logistics Agency awarded a $2,232.04 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, non-set-aside contract calls for performance at the vendor's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in military and federal healthcare settings to manage nausea and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,357.39 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a commonly used antiemetic medication in military and federal...
- The Defense Logistics Agency (DLA) awarded a $9,846.01 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in Conshohocken, PA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $27,576.18. The award was made on May 30, 2025, with an ultimate completion date of June 2, 2025. This delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global...
- The Defense Logistics Agency awarded a delivery order valued at $1,938.50 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packaging) on June 4, 2025, with completion scheduled for June 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in military and federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $6,859.46 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This non-set-aside, firm fixed-price contract was competitively awarded on June 7, 2025, with an ultimate completion date of June 9, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and headquarters. Ondansetron is a commonly...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA0WNDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,481.88 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count supply), with an ultimate completion date of July 1, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in military and federal healthcare settings to manage nausea and vomiting. This delivery order is a child contract executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and supplies a comprehensive range of pharmaceutical products and medical commodities to support military healthcare programs globally. The company's DLA prime vendor agreement enables flexible sourcing of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 6/30/25 |